Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CS-1036 Phase 2 Dose-Response Study in Type 2 Diabetes Mellitus
jRCT2080221036Phase 2
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of CS-1036 in type 2 diabetes mellitus (T2DM), sponsored by Daiichi Sankyo Co., Ltd.
02
Drugs
CS-1036
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080221036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221036.